Complete remission induced by thalidomide in a case of angioimmunoblastic T-cell lymphoma refractory to autologous stem cell transplantation

Leukemia and Lymphoma

Volumn 49, Issue 9, 2008, Pages 1836-1838

  Gottardi, Michele ^a   Danesin, Cristina ^a   Canal, Fabio ^b   Tos, Angelo Paolo Dei ^b   Stefani, Piero Maria ^a   Calistri, Elisabetta ^a   Salvadori, Ugo ^a   Gherlinzoni, Filippo ^a  

^a Haematology Unit   (Italy)

^b Treviso General Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; BLEOMYCIN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FOLINIC ACID; HAPTOGLOBIN; IFOSFAMIDE; MELPHALAN; METHOTREXATE; PREDNISONE; TENIPOSIDE; THALIDOMIDE; VINCRISTINE;

ADULT; ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CASE REPORT; CELL INFILTRATION; CLINICAL FEATURE; DRUG MEGADOSE; DRUG WITHDRAWAL; HUMAN; HYPERGAMMAGLOBULINEMIA; LYMPHADENOPATHY; LYMPHOMA CELL; MALE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; PANCYTOPENIA; PERIPHERAL NEUROPATHY; PLEURA EFFUSION; PRIORITY JOURNAL; SPLENOMEGALY; T CELL LYMPHOMA; TREATMENT RESPONSE;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOBLASTIC LYMPHADENOPATHY; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MIDDLE AGED; REMISSION INDUCTION; SALVAGE THERAPY; THALIDOMIDE; TRANSPLANTATION, AUTOLOGOUS;

EID: 52349115881     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802233165     Document Type: Article

References (9)

1. Gisselbrecht, C., Gaulard, P., Lapage, E., Coiffier, B., Briere, J. Haioun, C. et al. (1998) Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA). Blood, 92, pp. 76-82.
2. Schetelig, J., Fetscher, S., Reichle, A., Berdel, W. E., Bequin, Y. Brunet, S. et al. (2003) Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation. Haematologica, 88, pp. 1272-1278.
3. Rodriguez, J., Conde, E., Gutierrez, A., Arranz, R., Gandarillas, M. Leon, A. et al. (2007) Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: The GELTAMO experience. Eur J Haematol, 78, pp. 290-296.
4. Advani, R., Warnke, R., Sikic, B. I. and Horning, S. (1997) Treatment of angioimmunoblastic T-cell lymphoma with cyclosporine. Ann Oncol, 8, pp. 601-603.
5. Strupp, C., Aivado, M., Germing, U., Gattermann, N. and Haas, R. (2003) Angioimmunoblastic lymphadenopathy (AILD) may respond to thalidomide treatment: Two case reports. Leuk Lymphoma, 43, pp. 133-137.
6. Dogan, A., Ngu, L. S., Ng, S. H. and Cervi, P. L. (2005) Pathology and clinical features of angioimmunoblastic T-cell lymphoma after successful treatment with thalidomide. Leukemia, 19, pp. 873-875.
7. Damaj, G., Bouabdallah, R., Vey, N., Bilger, K., Mohty, M. and Gastaut, J. A. (2005) Single-agent thalidomide induces response in T-cell lymphoma. Eur J Haematol, 74, pp. 169-171.
8. Ramasamy, K., Lim, Z., Pagliuca, A., Salisbury, J. R., Mufti, G. J. and Devereux, S. (2006) Successful treatment of angioimmunoblastic T-cell lymphoma with thalidomide and dexamethasone. Haematologica, 91, pp. S26-S27.
9. Kyriakou, C., Canals, C., Goldstone, A., Caballero, D., Metzner, B. Kobbe, G. et al. (2008) High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: Complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol, 26, pp. 218-224.